| Symbol |
Name |
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ACP1
|
acid phosphatase 1, soluble
|
|
ADAM29
|
ADAM metallopeptidase domain 29
|
|
AICDA
|
activation-induced cytidine deaminase
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
AKT2
|
v-akt murine thymoma viral oncogene homolog 2
|
|
ALB
|
albumin
|
|
ANGPT2
|
angiopoietin 2
|
|
ANPEP
|
alanyl (membrane) aminopeptidase
|
|
ARHGAP20
|
Rho GTPase activating protein 20
|
|
ATM
|
ATM serine/threonine kinase
|
|
AXL
|
AXL receptor tyrosine kinase
|
|
B2M
|
beta-2-microglobulin
|
|
BAG3
|
BCL2-associated athanogene 3
|
|
BCL11A
|
B-cell CLL/lymphoma 11A (zinc finger protein)
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2L1
|
BCL2-like 1
|
|
BCL2L11
|
BCL2-like 11 (apoptosis facilitator)
|
|
BCL2L12
|
BCL2-like 12 (proline rich)
|
|
BCL6
|
B-cell CLL/lymphoma 6
|
|
BGN
|
biglycan
|
|
BTK
|
Bruton agammaglobulinemia tyrosine kinase
|
|
CCL11
|
chemokine (C-C motif) ligand 11
|
|
CCL19
|
chemokine (C-C motif) ligand 19
|
|
CCL21
|
chemokine (C-C motif) ligand 21
|
|
CD2
|
CD2 molecule
|
|
CD200
|
CD200 molecule
|
|
CD37
|
CD37 molecule
|
|
CD38
|
CD38 molecule
|
|
CD4
|
CD4 molecule
|
|
CD40
|
CD40 molecule, TNF receptor superfamily member 5
|
|
CD40LG
|
CD40 ligand
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CD52
|
CD52 molecule
|
|
CD70
|
CD70 molecule
|
|
CD74
|
CD74 molecule, major histocompatibility complex, class II invariant chain
|
|
CD83
|
CD83 molecule
|
|
CD84
|
CD84 molecule
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CLLU1
|
chronic lymphocytic leukemia up-regulated 1
|
|
CRY1
|
cryptochrome circadian clock 1
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
|
CX3CL1
|
chemokine (C-X3-C motif) ligand 1
|
|
CX3CR1
|
chemokine (C-X3-C motif) receptor 1
|
|
CXCL13
|
chemokine (C-X-C motif) ligand 13
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCR3
|
chemokine (C-X-C motif) receptor 3
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CXCR5
|
chemokine (C-X-C motif) receptor 5
|
|
CYLD
|
cylindromatosis (turban tumor syndrome)
|
|
CYSLTR1
|
cysteinyl leukotriene receptor 1
|
|
DAPK1
|
death-associated protein kinase 1
|
|
DAXX
|
death-domain associated protein
|
|
DCN
|
decorin
|
|
DICER1
|
dicer 1, ribonuclease type III
|
|
DLEU1
|
deleted in lymphocytic leukemia 1 (non-protein coding)
|
|
DLEU2
|
deleted in lymphocytic leukemia 2 (non-protein coding)
|
|
DOK1
|
docking protein 1, 62kDa (downstream of tyrosine kinase 1)
|
|
DPP8
|
dipeptidyl-peptidase 8
|
|
EFNA4
|
ephrin-A4
|
|
ENG
|
endoglin
|
|
EPHA10
|
EPH receptor A10
|
|
EPHB6
|
EPH receptor B6
|
|
EPO
|
erythropoietin
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
F2R
|
coagulation factor II (thrombin) receptor
|
|
FCER1G
|
Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide
|
|
FCER2
|
Fc fragment of IgE, low affinity II, receptor for (CD23)
|
|
FCMR
|
Fc fragment of IgM receptor
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
|
FLT1
|
fms-related tyrosine kinase 1
|
|
FLT4
|
fms-related tyrosine kinase 4
|
|
FMNL1
|
formin-like 1
|
|
GALNT11
|
polypeptide N-acetylgalactosaminyltransferase 11
|
|
GRN
|
granulin
|
|
HLA-G
|
major histocompatibility complex, class I, G
|
|
HMMR
|
hyaluronan-mediated motility receptor (RHAMM)
|
|
ID4
|
inhibitor of DNA binding 4, dominant negative helix-loop-helix protein
|
|
IFNGR1
|
interferon gamma receptor 1
|
|
IGH
|
immunoglobulin heavy locus
|
|
IGHV4-59
|
immunoglobulin heavy variable 4-59
|
|
IGK
|
immunoglobulin kappa locus
|
|
IL10
|
interleukin 10
|
|
IL21
|
interleukin 21
|
|
IL2RA
|
interleukin 2 receptor, alpha
|
|
IL6
|
interleukin 6
|
|
IRF4
|
interferon regulatory factor 4
|
|
IRF5
|
interferon regulatory factor 5
|
|
ITCH
|
itchy E3 ubiquitin protein ligase
|
|
ITGA4
|
integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor)
|
|
ITGAM
|
integrin, alpha M (complement component 3 receptor 3 subunit)
|
|
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
|
|
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)
|
|
ITGB7
|
integrin, beta 7
|
|
KDR
|
kinase insert domain receptor
|
|
LAIR1
|
leukocyte-associated immunoglobulin-like receptor 1
|
|
LCK
|
LCK proto-oncogene, Src family tyrosine kinase
|
|
LEF1
|
lymphoid enhancer-binding factor 1
|
|
LILRB4
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 4
|
|
LPAR1
|
lysophosphatidic acid receptor 1
|
|
LPAR2
|
lysophosphatidic acid receptor 2
|
|
LPAR3
|
lysophosphatidic acid receptor 3
|
|
LPAR4
|
lysophosphatidic acid receptor 4
|
|
LPAR5
|
lysophosphatidic acid receptor 5
|
|
LPL
|
lipoprotein lipase
|
|
MAP3K12
|
mitogen-activated protein kinase kinase kinase 12
|
|
MCL1
|
myeloid cell leukemia 1
|
|
MIR106B
|
microRNA 106b
|
|
MIR125A
|
microRNA 125a
|
|
MIR155
|
microRNA 155
|
|
MIR15A
|
microRNA 15a
|
|
MIR16-1
|
microRNA 16-1
|
|
MIR17
|
microRNA 17
|
|
MIR22
|
microRNA 22
|
|
MIR29A
|
microRNA 29a
|
|
MIR29B1
|
microRNA 29b-1
|
|
MIR29C
|
microRNA 29c
|
|
MIR34A
|
microRNA 34a
|
|
MIR650
|
microRNA 650
|
|
MKI67
|
marker of proliferation Ki-67
|
|
MPO
|
myeloperoxidase
|
|
MS4A1
|
membrane-spanning 4-domains, subfamily A, member 1
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYCN
|
v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog
|
|
MYH9
|
myosin, heavy chain 9, non-muscle
|
|
NFATC1
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1
|
|
NFKB2
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100)
|
|
NOTCH1
|
notch 1
|
|
P2RX7
|
purinergic receptor P2X, ligand gated ion channel, 7
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
|
PDCD1
|
programmed cell death 1
|
|
PDE7B
|
phosphodiesterase 7B
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIK3CD
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta
|
|
PMAIP1
|
phorbol-12-myristate-13-acetate-induced protein 1
|
|
PRAME
|
preferentially expressed antigen in melanoma
|
|
PRELP
|
proline/arginine-rich end leucine-rich repeat protein
|
|
PRKCB
|
protein kinase C, beta
|
|
PRKCH
|
protein kinase C, eta
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTK2
|
protein tyrosine kinase 2
|
|
PTPN22
|
protein tyrosine phosphatase, non-receptor type 22 (lymphoid)
|
|
PTPRC
|
protein tyrosine phosphatase, receptor type, C
|
|
RAD51
|
RAD51 recombinase
|
|
RAD52
|
RAD52 homolog (S. cerevisiae)
|
|
RAD54L
|
RAD54-like (S. cerevisiae)
|
|
REL
|
v-rel avian reticuloendotheliosis viral oncogene homolog
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
RHD
|
Rh blood group, D antigen
|
|
RHOH
|
ras homolog family member H
|
|
ROR1
|
receptor tyrosine kinase-like orphan receptor 1
|
|
SF3B1
|
splicing factor 3b, subunit 1, 155kDa
|
|
SFRP1
|
secreted frizzled-related protein 1
|
|
SLC4A1
|
solute carrier family 4 (anion exchanger), member 1 (Diego blood group)
|
|
SMAD7
|
SMAD family member 7
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
SYK
|
spleen tyrosine kinase
|
|
TAP2
|
transporter 2, ATP-binding cassette, sub-family B (MDR/TAP)
|
|
TCF3
|
transcription factor 3
|
|
TCL1A
|
T-cell leukemia/lymphoma 1A
|
|
TERF2
|
telomeric repeat binding factor 2
|
|
TERT
|
telomerase reverse transcriptase
|
|
TFRC
|
transferrin receptor
|
|
THBS1
|
thrombospondin 1
|
|
TLR7
|
toll-like receptor 7
|
|
TNF
|
tumor necrosis factor
|
|
TNFAIP3
|
tumor necrosis factor, alpha-induced protein 3
|
|
TNFRSF10A
|
tumor necrosis factor receptor superfamily, member 10a
|
|
TNFRSF13C
|
tumor necrosis factor receptor superfamily, member 13C
|
|
TNFRSF18
|
tumor necrosis factor receptor superfamily, member 18
|
|
TNFRSF9
|
tumor necrosis factor receptor superfamily, member 9
|
|
TNFSF10
|
tumor necrosis factor (ligand) superfamily, member 10
|
|
TNFSF13B
|
tumor necrosis factor (ligand) superfamily, member 13b
|
|
TP53
|
tumor protein p53
|
|
TP73
|
tumor protein p73
|
|
TPO
|
thyroid peroxidase
|
|
TRIP10
|
thyroid hormone receptor interactor 10
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VHL
|
von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase
|
|
WNT10A
|
wingless-type MMTV integration site family, member 10A
|
|
WNT16
|
wingless-type MMTV integration site family, member 16
|
|
WNT3
|
wingless-type MMTV integration site family, member 3
|
|
WNT4
|
wingless-type MMTV integration site family, member 4
|
|
WNT5B
|
wingless-type MMTV integration site family, member 5B
|
|
WNT7B
|
wingless-type MMTV integration site family, member 7B
|
|
WNT9A
|
wingless-type MMTV integration site family, member 9A
|
|
ZAP70
|
zeta-chain (TCR) associated protein kinase 70kDa
|
